CN Stock MarketDetailed Quotes

Yifeng Pharmacy Chain (603939)

Watchlist
  • 22.13
  • -0.90-3.91%
Market Closed May 18 15:00 CST
26.83BMarket Cap15.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yifeng Pharmacy Chain (603939) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
1.26%6.09B
1.54%24.43B
0.39%17.29B
-0.35%11.72B
0.64%6.01B
6.53%24.06B
8.38%17.22B
9.86%11.76B
13.39%5.97B
13.59%22.59B
Operating revenue
1.26%6.09B
1.54%24.43B
0.39%17.29B
-0.35%11.72B
0.64%6.01B
6.53%24.06B
8.38%17.22B
9.86%11.76B
13.39%5.97B
13.59%22.59B
Other operating revenue
----
-8.71%700.33M
----
-3.64%353.91M
----
50.22%767.13M
----
30.14%367.28M
----
1.20%510.66M
Total operating cost
-0.09%5.39B
0.71%22.13B
-0.51%15.63B
-1.30%10.54B
-0.06%5.39B
6.58%21.97B
8.57%15.71B
9.81%10.68B
12.79%5.39B
14.48%20.62B
Operating cost
0.60%3.65B
2.84%14.82B
0.37%10.3B
-1.04%6.98B
-0.01%3.63B
3.23%14.41B
6.86%10.26B
9.76%7.05B
14.17%3.63B
16.07%13.96B
Operating tax surcharges
6.92%24.4M
5.68%100.91M
2.47%70.72M
-6.48%45.09M
-1.35%22.82M
6.82%95.49M
19.69%69.01M
28.24%48.21M
29.15%23.14M
27.23%89.39M
Operating expense
-3.20%1.37B
-5.26%5.85B
-3.61%4.31B
-3.57%2.9B
-2.96%1.41B
12.61%6.18B
10.44%4.48B
9.23%3.01B
8.07%1.46B
12.49%5.49B
Administration expense
11.24%310.56M
9.58%1.19B
7.21%810.66M
8.23%521.18M
12.07%279.18M
12.52%1.08B
11.38%756.15M
4.71%481.53M
16.09%249.12M
6.46%962.42M
Financial expense
-32.24%27.98M
-18.31%142.06M
-7.68%113.02M
9.42%79.97M
47.49%41.3M
101.78%173.9M
94.31%122.43M
85.83%73.08M
38.98%28M
-17.77%86.18M
-Interest expense (Financial expense)
-34.74%31.85M
-24.67%166.75M
-10.65%142.6M
-1.66%101.03M
10.00%48.8M
37.90%221.37M
30.46%159.59M
28.59%102.74M
11.81%44.36M
-2.83%160.53M
-Interest Income (Financial expense)
46.62%-7.47M
34.59%-47.52M
15.57%-46.84M
21.16%-33.13M
36.81%-13.99M
22.12%-72.65M
23.60%-55.48M
16.81%-42.02M
10.94%-22.13M
-27.43%-93.29M
Research and development
-14.20%5.85M
-17.74%27.92M
-14.59%21.51M
-11.13%14.99M
-30.19%6.82M
1.15%33.94M
65.08%25.19M
71.11%16.87M
110.72%9.77M
32.56%33.55M
Credit Impairment Loss
52.56%-1.23M
-101.72%-36.99K
224.73%2.69M
545.44%2.35M
-183.12%-2.58M
147.49%2.15M
-632.93%-2.15M
-122.01%-526.56K
6.97%3.11M
56.65%-4.54M
Asset Impairment Loss
-4.29%-23.74M
-9.00%-111.61M
-19.91%-71.65M
-19.83%-46.49M
-17.94%-22.76M
-40.98%-102.4M
-11.78%-59.75M
-12.10%-38.8M
-14.37%-19.3M
-29.66%-72.63M
Adjustment items of total operating cost
----
----
----
----
----
----
----
----
0.00%-0.01
----
Other net revenue
-11.52%28.82M
29.53%149.69M
68.33%132.4M
82.96%88.66M
90.14%32.58M
38.97%115.56M
49.91%78.66M
-1.52%48.46M
-6.94%17.13M
1,021.85%83.16M
Invest income
2.14%27.77M
15.37%124.75M
29.90%99.77M
40.17%69.31M
82.09%27.19M
155.19%108.13M
111.89%76.8M
65.79%49.45M
224.32%14.93M
516.89%42.37M
-Including: Investment income associates
----
----
----
----
----
-100.28%-901.4
39.10%-974.75
42.22%-903.14
-1,277.48%-453.88
2,873.81%316.57K
Asset deal income
-32.25%11.36M
37.13%68.48M
114.03%48.84M
126.55%33.87M
147.24%16.76M
19.42%49.94M
2.64%22.82M
-2.77%14.95M
48.19%6.78M
80.51%41.82M
Other revenue
4.95%14.67M
17.97%68.11M
28.86%52.76M
26.69%29.63M
20.32%13.98M
-24.17%57.74M
-12.97%40.94M
-35.43%23.38M
-49.94%11.62M
73.58%76.13M
Operating profit
11.86%727.66M
11.34%2.45B
12.69%1.79B
12.20%1.27B
9.61%650.54M
7.25%2.2B
7.95%1.59B
9.80%1.13B
18.31%593.52M
8.98%2.05B
Add:Non operating Income
35.37%2.13M
196.45%37.75M
-14.47%6.95M
-24.95%4.06M
-35.74%1.58M
0.24%12.74M
14.64%8.13M
16.74%5.41M
71.30%2.45M
3.78%12.7M
Less:Non operating expense
43.59%6.16M
2.85%35.08M
73.96%23.8M
62.64%12.82M
56.70%4.29M
14.10%34.11M
68.84%13.68M
39.13%7.88M
20.62%2.74M
47.36%29.9M
Total profit
11.70%723.64M
12.55%2.46B
12.02%1.77B
11.67%1.26B
9.20%647.83M
7.11%2.18B
7.64%1.58B
9.67%1.13B
18.45%593.24M
8.53%2.04B
Less:Income tax cost
15.09%177.55M
18.07%625.37M
17.62%448.79M
17.08%317.8M
4.75%154.28M
15.99%529.67M
12.38%381.57M
16.57%271.43M
21.78%147.29M
0.57%456.66M
Add:Adjusted items effecting net profit
----
----
----
---0.01
----
----
----
----
----
----
Net profit
10.64%546.09M
10.78%1.83B
10.24%1.32B
9.97%945.79M
10.67%493.55M
4.54%1.65B
6.22%1.2B
7.66%860.07M
17.40%445.95M
11.07%1.58B
Net profit from continuing operation
10.64%546.09M
10.78%1.83B
10.24%1.32B
9.97%945.79M
10.67%493.55M
4.54%1.65B
6.22%1.2B
7.66%860.07M
17.40%445.95M
11.07%1.58B
Less:Minority Profit
5.63%46.54M
22.82%152.54M
9.89%96.61M
5.45%65.75M
12.39%44.06M
-26.48%124.21M
-31.89%87.92M
-33.46%62.35M
-9.66%39.2M
4.56%168.95M
Net profit of parent company owners
11.14%499.55M
9.81%1.68B
10.27%1.22B
10.32%880.05M
10.51%449.49M
8.26%1.53B
11.14%1.11B
13.13%797.72M
20.89%406.75M
11.90%1.41B
Add:Adjusted items effecting net profit of parent company owners
----
----
----
0.00%-0.01
----
----
----
---0.01
----
----
Earning per share
Basic earning per share
10.81%0.41
9.52%1.38
9.78%1.01
10.61%0.73
12.12%0.37
7.69%1.26
10.84%0.92
13.79%0.66
-2.94%0.33
-7.14%1.17
Diluted earning per share
11.11%0.4
9.68%1.36
7.61%0.99
7.58%0.71
9.09%0.36
5.98%1.24
10.84%0.92
13.79%0.66
-2.94%0.33
-6.40%1.17
Other composite income
208.51%75.08M
153.46%47.77M
127.01%32.35M
121.74%9.61M
-280.10%-69.19M
-205.31%-89.37M
-176.03%-119.8M
-148.79%-44.2M
325.97%38.42M
Other composite income of parent company owners
----
208.51%75.08M
153.46%47.77M
127.01%32.35M
121.74%9.61M
-280.10%-69.19M
-205.31%-89.37M
-176.03%-119.8M
-148.79%-44.2M
325.97%38.42M
Total composite income
8.53%546.09M
20.37%1.91B
23.43%1.37B
32.13%978.15M
25.24%503.16M
-2.21%1.58B
-8.58%1.11B
-22.60%740.27M
-14.61%401.75M
15.14%1.62B
Total composite income of parent company owners
8.81%499.55M
20.16%1.75B
24.60%1.27B
34.59%912.4M
26.63%459.1M
0.62%1.46B
-5.80%1.02B
-21.42%677.92M
-15.11%362.55M
16.51%1.45B
Total composite income of minority owners
5.63%46.54M
22.82%152.54M
9.89%96.61M
5.45%65.75M
12.39%44.06M
-26.48%124.21M
-31.89%87.92M
-33.46%62.35M
-9.66%39.2M
4.56%168.95M
Add:Adjusted items effecting total composite income
----
----
----
0.00%-0.01
----
----
----
---0.01
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 1.26%6.09B1.54%24.43B0.39%17.29B-0.35%11.72B0.64%6.01B6.53%24.06B8.38%17.22B9.86%11.76B13.39%5.97B13.59%22.59B
Operating revenue 1.26%6.09B1.54%24.43B0.39%17.29B-0.35%11.72B0.64%6.01B6.53%24.06B8.38%17.22B9.86%11.76B13.39%5.97B13.59%22.59B
Other operating revenue -----8.71%700.33M-----3.64%353.91M----50.22%767.13M----30.14%367.28M----1.20%510.66M
Total operating cost -0.09%5.39B0.71%22.13B-0.51%15.63B-1.30%10.54B-0.06%5.39B6.58%21.97B8.57%15.71B9.81%10.68B12.79%5.39B14.48%20.62B
Operating cost 0.60%3.65B2.84%14.82B0.37%10.3B-1.04%6.98B-0.01%3.63B3.23%14.41B6.86%10.26B9.76%7.05B14.17%3.63B16.07%13.96B
Operating tax surcharges 6.92%24.4M5.68%100.91M2.47%70.72M-6.48%45.09M-1.35%22.82M6.82%95.49M19.69%69.01M28.24%48.21M29.15%23.14M27.23%89.39M
Operating expense -3.20%1.37B-5.26%5.85B-3.61%4.31B-3.57%2.9B-2.96%1.41B12.61%6.18B10.44%4.48B9.23%3.01B8.07%1.46B12.49%5.49B
Administration expense 11.24%310.56M9.58%1.19B7.21%810.66M8.23%521.18M12.07%279.18M12.52%1.08B11.38%756.15M4.71%481.53M16.09%249.12M6.46%962.42M
Financial expense -32.24%27.98M-18.31%142.06M-7.68%113.02M9.42%79.97M47.49%41.3M101.78%173.9M94.31%122.43M85.83%73.08M38.98%28M-17.77%86.18M
-Interest expense (Financial expense) -34.74%31.85M-24.67%166.75M-10.65%142.6M-1.66%101.03M10.00%48.8M37.90%221.37M30.46%159.59M28.59%102.74M11.81%44.36M-2.83%160.53M
-Interest Income (Financial expense) 46.62%-7.47M34.59%-47.52M15.57%-46.84M21.16%-33.13M36.81%-13.99M22.12%-72.65M23.60%-55.48M16.81%-42.02M10.94%-22.13M-27.43%-93.29M
Research and development -14.20%5.85M-17.74%27.92M-14.59%21.51M-11.13%14.99M-30.19%6.82M1.15%33.94M65.08%25.19M71.11%16.87M110.72%9.77M32.56%33.55M
Credit Impairment Loss 52.56%-1.23M-101.72%-36.99K224.73%2.69M545.44%2.35M-183.12%-2.58M147.49%2.15M-632.93%-2.15M-122.01%-526.56K6.97%3.11M56.65%-4.54M
Asset Impairment Loss -4.29%-23.74M-9.00%-111.61M-19.91%-71.65M-19.83%-46.49M-17.94%-22.76M-40.98%-102.4M-11.78%-59.75M-12.10%-38.8M-14.37%-19.3M-29.66%-72.63M
Adjustment items of total operating cost --------------------------------0.00%-0.01----
Other net revenue -11.52%28.82M29.53%149.69M68.33%132.4M82.96%88.66M90.14%32.58M38.97%115.56M49.91%78.66M-1.52%48.46M-6.94%17.13M1,021.85%83.16M
Invest income 2.14%27.77M15.37%124.75M29.90%99.77M40.17%69.31M82.09%27.19M155.19%108.13M111.89%76.8M65.79%49.45M224.32%14.93M516.89%42.37M
-Including: Investment income associates ---------------------100.28%-901.439.10%-974.7542.22%-903.14-1,277.48%-453.882,873.81%316.57K
Asset deal income -32.25%11.36M37.13%68.48M114.03%48.84M126.55%33.87M147.24%16.76M19.42%49.94M2.64%22.82M-2.77%14.95M48.19%6.78M80.51%41.82M
Other revenue 4.95%14.67M17.97%68.11M28.86%52.76M26.69%29.63M20.32%13.98M-24.17%57.74M-12.97%40.94M-35.43%23.38M-49.94%11.62M73.58%76.13M
Operating profit 11.86%727.66M11.34%2.45B12.69%1.79B12.20%1.27B9.61%650.54M7.25%2.2B7.95%1.59B9.80%1.13B18.31%593.52M8.98%2.05B
Add:Non operating Income 35.37%2.13M196.45%37.75M-14.47%6.95M-24.95%4.06M-35.74%1.58M0.24%12.74M14.64%8.13M16.74%5.41M71.30%2.45M3.78%12.7M
Less:Non operating expense 43.59%6.16M2.85%35.08M73.96%23.8M62.64%12.82M56.70%4.29M14.10%34.11M68.84%13.68M39.13%7.88M20.62%2.74M47.36%29.9M
Total profit 11.70%723.64M12.55%2.46B12.02%1.77B11.67%1.26B9.20%647.83M7.11%2.18B7.64%1.58B9.67%1.13B18.45%593.24M8.53%2.04B
Less:Income tax cost 15.09%177.55M18.07%625.37M17.62%448.79M17.08%317.8M4.75%154.28M15.99%529.67M12.38%381.57M16.57%271.43M21.78%147.29M0.57%456.66M
Add:Adjusted items effecting net profit ---------------0.01------------------------
Net profit 10.64%546.09M10.78%1.83B10.24%1.32B9.97%945.79M10.67%493.55M4.54%1.65B6.22%1.2B7.66%860.07M17.40%445.95M11.07%1.58B
Net profit from continuing operation 10.64%546.09M10.78%1.83B10.24%1.32B9.97%945.79M10.67%493.55M4.54%1.65B6.22%1.2B7.66%860.07M17.40%445.95M11.07%1.58B
Less:Minority Profit 5.63%46.54M22.82%152.54M9.89%96.61M5.45%65.75M12.39%44.06M-26.48%124.21M-31.89%87.92M-33.46%62.35M-9.66%39.2M4.56%168.95M
Net profit of parent company owners 11.14%499.55M9.81%1.68B10.27%1.22B10.32%880.05M10.51%449.49M8.26%1.53B11.14%1.11B13.13%797.72M20.89%406.75M11.90%1.41B
Add:Adjusted items effecting net profit of parent company owners ------------0.00%-0.01---------------0.01--------
Earning per share
Basic earning per share 10.81%0.419.52%1.389.78%1.0110.61%0.7312.12%0.377.69%1.2610.84%0.9213.79%0.66-2.94%0.33-7.14%1.17
Diluted earning per share 11.11%0.49.68%1.367.61%0.997.58%0.719.09%0.365.98%1.2410.84%0.9213.79%0.66-2.94%0.33-6.40%1.17
Other composite income 208.51%75.08M153.46%47.77M127.01%32.35M121.74%9.61M-280.10%-69.19M-205.31%-89.37M-176.03%-119.8M-148.79%-44.2M325.97%38.42M
Other composite income of parent company owners ----208.51%75.08M153.46%47.77M127.01%32.35M121.74%9.61M-280.10%-69.19M-205.31%-89.37M-176.03%-119.8M-148.79%-44.2M325.97%38.42M
Total composite income 8.53%546.09M20.37%1.91B23.43%1.37B32.13%978.15M25.24%503.16M-2.21%1.58B-8.58%1.11B-22.60%740.27M-14.61%401.75M15.14%1.62B
Total composite income of parent company owners 8.81%499.55M20.16%1.75B24.60%1.27B34.59%912.4M26.63%459.1M0.62%1.46B-5.80%1.02B-21.42%677.92M-15.11%362.55M16.51%1.45B
Total composite income of minority owners 5.63%46.54M22.82%152.54M9.89%96.61M5.45%65.75M12.39%44.06M-26.48%124.21M-31.89%87.92M-33.46%62.35M-9.66%39.2M4.56%168.95M
Add:Adjusted items effecting total composite income ------------0.00%-0.01---------------0.01--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.81%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.82%
4
SINOPEC CORP
00386
-1.54%
5
SHANGHAI PECHEM
00338
-2.36%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +36.67%
Sample Name
Sample Code
 +29.14%
Sample Name
Sample Code
 +25.72%
4
Digital China Group
000034
+19.11%
5
Business-intelligence Of Oriental Nations Corporation
300166
+17.75%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -